Presented on .
The November session of Grand Rounds “The National Diabetes Prevention Program — Changing Lifestyles to Prevent Type 2 Diabetes,” was viewed in 6 foreign countries and in 42 states, plus the District of Columbia.
Diabetes is a serious public health problem. About 30 million Americans have diabetes, and more than 84 million American adults have prediabetes. People with prediabetes have blood sugar levels that are higher than normal, but not high enough to be diagnosed with type 2 diabetes. They are at risk for type 2 diabetes, heart attack and stroke, but lifestyle changes, such as losing weight and increasing physical activity, can reduce their risk and may even prevent the onset of type 2 diabetes.
The CDC-led National Diabetes Prevention Program (National DPP) is a proven program that helps people with prediabetes make lifestyle changes that last. Individuals who took the yearlong program were less likely to develop type 2 diabetes, even 15 years later. Preventing or delaying new cases of type 2 diabetes and improving outcomes for people living with prediabetes are critical public health needs.
Please join us for this session of Grand Rounds to learn about how the National DPP, and the Medicare Diabetes Prevention Program and others are supporting people with prediabetes to make life-long changes.
Beyond the Data - The National Diabetes Prevention Program: Changing Lifestyles to Prevent Type 2 Diabetes
- Ann Albright, PhD, RDN
Division of Diabetes Translation
"Moving Evidence to Action to Prevent Type 2 Diabetes"
- Nina Brown-Ashford, MPH, CHES
- Deputy Director
Preventive and Population Health Group
Center for Medicare and Medicaid Innovation
"The Expanded Model of Diabetes Prevention Program from Medicare"
- David P Pryor, MD, MPH
- Regional Vice-President Medical Director
Anthem Blue Cross California, Commercial Accounts
"A National Coverage Model for the National DPP Lifestyle Change Program"
- Arlene Guindon, MPH
- Senior Program Manager
National Kidney Foundation of Michigan
"Real World Implementation of the National DPP"
- John Iskander, MD, MPH
- Scientific Director
- Phoebe Thorpe, MD, MPH
- Deputy Scientific Director
- Susan Laird, MSN, RN
- Communications Director
Enjoyed this Presentation?
You May Also Like
ALS is a rapidly progressive, fatal neurological disease. Researchers don’t know what causes ALS and there is no cure. The National ALS Registry was created in 2010 to help scientists learn who gets ALS and what causes it. Learn about research, drug development, and patient care options and the role of the ALS Registry.
The risk factors for cancer are many and varied. Inherited genetic mutations play a major role in 5 to 10 % of all cancers. When genetic mutations are identified early, patients are able to work with their healthcare providers. Find out how public health agencies are evolving in the rapidly growing field of genomics.
- Page last reviewed: November 13, 2018
- Page last updated: November 13, 2018
- Content source:
- Office of the Associate Director for Science
- Page maintained by: Office of the Associate Director for Communication